1 patient evaluation for Adalimumab taken for the purpose of 'Crohn's disease' with a perceived effectiveness rating of Can’t tell

10 members have decided to share their profiles only with other members of PatientsLikeMe.

Apr 22, 2011 (Started Apr 13, 2011)

  • Effectiveness
    Can't tell (for Crohn's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 20 mg/0.4 mL Every Other Week

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Adalimumab